4271.0 Medication Assisted Treatment: Innovative Findings and Practices

Tuesday, November 1, 2011: 2:30 PM
Medication assisted treatment programs vary considerably in their practices, which can impact outcomes. This session looks at correlates of staff characteristics and program practices, comparison of buprenorphine vs methadone pharmacotherapy, retention of Hispanic injection drug abusers, and management of pain among opioid abusers.
Session Objectives: Discuss factors associated with medication assisted therapy practices in opioid treatment programs.
Sean J. Haley, PhD, MPH

2:30 PM
Community-based addiction treatment clinical trials: Site variation
Dennis McCarty, PhD, Allie Buti, MPH, Lynn Kunkel, MS, CCRP, Holly Fussell, PhD, Danielle Eakins, BA and Michele Straus, RPh, MS
3:10 PM
Factors associated with outpatient methadone maintenance treatment retention among Hispanic injection drug users
René R. Dávila-Torres, MS, DBA, PhD, Gary J. Burkholder, PhD, Margarita Alegria, PhD, Maria Rangel, PhD and William M. Barkley, PhD
3:30 PM
Epidemiology of pain among drug users in methadone maintenance
Lara Dhingra, PhD, Carmen L. Masson, PhD, David C. Perlman, MD, Randy M. Seewald, MD, Courtney McKnight, MPH, Ashly E. Jordan, BA, Jessica Hall, BS, Christopher Young, BA, Judith Katz, BS, Emily Wald, BA, Kevin L. Delucchi, PhD and Russell Portenoy, MD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: Latino Caucus, Public Health Education and Health Promotion, Public Health Nursing, Community-Based Public Health Caucus, Community Health Planning and Policy Development

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)